Answers are grounded in this paper and cite their sources.
The results of this general practice study suggest that acetylcysteine (Fabrol) administered orally for 2 months to patients with chronic bronchitis effectively changes the viscosity and character of sputum with resultant ease of expectoration and cough severity. There was a notable improvement in associated abnormal physical signs such as the presence of rhonchi, crepitations and symptoms including dyspnoea at rest. Tolerability was good, with 81% of patients experiencing no side-effects.
No takes yet. Share an insight, caveat, or question.
Tattersall et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: